SCHEMBL6002923

SCHEMBL6002923

Cc1ccc(OCCc2n[c]cs2)cc1C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 7/20 0.45
NPC1 O15118 6/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
HTT P42858 2/20 0.40
DRD2 P14416 1/20 0.40
DRD4 P21917 1/20 0.40
DRD3 P35462 1/20 0.40
MAPT P10636 4/20 0.39
CYP1A2 P05177 3/20 0.39
CYP3A4 P08684 3/20 0.39
CYP2C19 P33261 3/20 0.39
CYP2D6 P10635 2/20 0.39
KDM4E B2RXH2 1/20 0.39
HSP90AA1 P07900 1/20 0.37
TDP1 Q9NUW8 1/20 0.36
CYP2C9 P11712 2/20 0.36
ALDH1A1 P00352 2/20 0.36
FFAR1 O14842 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5013360 0.87 RAB9A (0.55) RAB9ANPC1MEN1KMT2ASMN1; SMN2
SCHEMBL6002811 0.77 HRH3 (0.39) RAB9AMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL3763682 0.72 DRD2 (0.58) RAB9ANPC1MEN1KMT2ASMN1; SMN2
SCHEMBL2749917 0.71 HAO1 (0.41) RAB9ANPC1MEN1KMT2ASMN1; SMN2
SCHEMBL2094591 0.71 RAB9A (0.37) RAB9ANPC1HTTMAPT
SCHEMBL17637581 0.70 DRD2 (0.61) RAB9ANPC1MEN1KMT2ASMN1; SMN2
SCHEMBL12337966 0.67 RAB9A (0.57) RAB9ANPC1SMN1; SMN2MAPTHSP90AA1
SCHEMBL15760678 0.67 KDM4E (0.53) RAB9ANPC1MEN1KMT2ASMN1; SMN2
SCHEMBL469900 0.67 DRD2 (0.53) RAB9ANPC1MEN1KMT2ASMN1; SMN2
SCHEMBL11365687 0.67 DRD2 (0.57) RAB9ANPC1MEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678185-A1 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-07-12 EP disclosed
WO-2005042542-A1 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-05-12 WO disclosed